These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27231313)

  • 1. Predicting outcomes to anti-vascular endothelial growth factor (VEGF) therapy in diabetic macular oedema: a review of the literature.
    Ashraf M; Souka A; Adelman R
    Br J Ophthalmol; 2016 Dec; 100(12):1596-1604. PubMed ID: 27231313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
    Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
    Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab for diabetic macular oedema: 5-year results of the Pan-American Collaborative Retina Study group.
    Arevalo JF; Lasave AF; Wu L; Acon D; Farah ME; Gallego-Pinazo R; Alezzandrini AA; Fortuna V; Quiroz-Mercado H; Salcedo-Villanueva G; Maia M; Serrano M; Rojas S;
    Br J Ophthalmol; 2016 Dec; 100(12):1605-1610. PubMed ID: 26912377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
    Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
    Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.
    Heier JS; Bressler NM; Avery RL; Bakri SJ; Boyer DS; Brown DM; Dugel PU; Freund KB; Glassman AR; Kim JE; Martin DF; Pollack JS; Regillo CD; Rosenfeld PJ; Schachat AP; Wells JA;
    JAMA Ophthalmol; 2016 Jan; 134(1):95-9. PubMed ID: 26512939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor and diabetic macular edema.
    Lally DR; Shah CP; Heier JS
    Surv Ophthalmol; 2016; 61(6):759-768. PubMed ID: 27045225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review on Recent Trials Evaluating the Effect of Intravitreal Injections of Anti-VEGF Agents on the Macular Perfusion of Diabetic Patients with Diabetic Macular Edema.
    Elnahry AG; Abdel-Kader AA; Habib AE; Elnahry GA; Raafat KA; Elrakhawy K
    Rev Recent Clin Trials; 2020; 15(3):188-198. PubMed ID: 32427087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of diabetic macular oedema using ultra-widefield angiography and implications for response to anti-VEGF therapy.
    Xue K; Yang E; Chong NV
    Br J Ophthalmol; 2017 May; 101(5):559-563. PubMed ID: 27531355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macular Hole Formation after Intravitreal Injection of Bevacizumab for Diabetic Macular Edema.
    Lee YJ; Kim M
    Korean J Ophthalmol; 2019 Apr; 33(2):198-199. PubMed ID: 30977331
    [No Abstract]   [Full Text] [Related]  

  • 12. Optical Coherence Tomography Features in Diabetic Macular Edema and the Impact on Anti-VEGF Response.
    Itoh Y; Petkovsek D; Kaiser PK; Singh RP; Ehlers JP
    Ophthalmic Surg Lasers Imaging Retina; 2016 Oct; 47(10):908-913. PubMed ID: 27759856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of serous retinal detachment on the efficacy of ranibizumab in diabetic macular oedema.
    Qu-Knafo LM; Fajnkuchen F; Sarda V; Boubaya M; Levy V; Chaine G; Giocanti-Auregan A
    Acta Ophthalmol; 2017 Aug; 95(5):e434-e435. PubMed ID: 26823130
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of time- and spectral-domain optical coherence tomography in management of diabetic macular edema.
    Liu MM; Wolfson Y; Bressler SB; Do DV; Ying HS; Bressler NM
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1370-7. PubMed ID: 24526445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal ranibizumab for diabetic macular oedema in previously vitrectomized eyes.
    Laugesen CS; Ostri C; Brynskov T; Lund-Andersen H; Larsen M; Vorum H; Sørensen TL
    Acta Ophthalmol; 2017 Feb; 95(1):28-32. PubMed ID: 27473397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment.
    Bressler SB; Ayala AR; Bressler NM; Melia M; Qin H; Ferris FL; Flaxel CJ; Friedman SM; Glassman AR; Jampol LM; Rauser ME;
    JAMA Ophthalmol; 2016 Mar; 134(3):278-85. PubMed ID: 26746868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of fundus autofluorescence with spectral-domain optical coherence tomography and vision in diabetic macular edema.
    Chung H; Park B; Shin HJ; Kim HC
    Ophthalmology; 2012 May; 119(5):1056-65. PubMed ID: 22342014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic Macular Edema: Options for Adjunct Therapy.
    Calvo P; Abadia B; Ferreras A; Ruiz-Moreno O; Verdes G; Pablo LE
    Drugs; 2015 Sep; 75(13):1461-9. PubMed ID: 26242766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of foveal capillary drop-out and previous panretinal photocoagulation for diabetic macular oedema treated with ranibizumab.
    Ebneter A; Wolf S; Zinkernagel MS
    Br J Ophthalmol; 2016 Mar; 100(3):365-70. PubMed ID: 26187951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.